Compound Prevents Neurodegeneration


Compound Prevents Neurodegeneration

Neurochemistry: Small molecule  alleviates Alzheimer’s, Huntington’s symptoms in animals

Stu Borman

Researchers have identified and tested a compound that reverses and prevents symptoms of neurodegenerative diseases like Alzheimer’s and Huntington’s in animal models (Cell, DOI: 10.1016/j.cell.2011.05.020; Curr. Biol., DOI: 10.1016/j.cub.2011.04.028). Neurodegeneration, the breakdown or death of neurons, causes losses in one’s ability to think, move, and communicate, often leading to death.

The compound, JM6, offers new hope for treating these diseases, for which new medications are urgently needed. Still, JM6’s safety and efficacy have yet to be confirmed in clinical trials.

The work was carried out by neuropharmacologist Robert Schwarcz of the University of Maryland School of Medicine; neurodegeneration specialist Paul J. Muchowski and his father, synthetic chemist Joseph M. Muchowski, both of Gladstone Institute of Neurological Disease; neurogeneticist Flaviano Giorgini of the University of Leicester, England; and coworkers. The research team hopes to have JM6 in human trials within two years, sponsored by a major drug firm or by a biotech company they are thinking about starting.

In animals, JM6 converts to an inhibitor of kynuren ine 3-monooxygenase, an enzyme that controls the kynurenine pathway, long believed to be implicated in neurodegeneration. This link was established to a large degree by Schwarcz’s group.

Levels of nerve-damaging kynurenine metabolites are elevated, and those of a neuroprotective one are lowered, in the blood of patients with neurodegenerative diseases. The researchers show that administering JM6 to animals with neurodegenerative diseases causes levels of the damaging and protective metabolites to normalize, leading to reversal and prevention of neuron damage.

JM6’s activity “seems like a fairy tale—almost too good to be true,” says Stephen Snyder, a deputy division director at the National Institute on Aging. “But intuitively you want JM6 to work out because it is simple and elegant, it’s good for the brain, and it appears to be nontoxic.”

July 25, 2011

Dow Unveils Largest Project Ever

Middle East: With Saudi Aramco, firm will move On $20 billion petrochemicals joint venture.

Furniture Linked To PBDE Levels In Pregnant Women

Toxic Substances: Women with more stuffed furniture had higher blood levels of the flame retardants.

Water Disinfectant Turns Medical Compounds Toxic

Disinfection By-Products: Medical imaging chemicals transform into toxic compounds in drinking water treated with chlorine.

One Home For Various Guests

Supramolecular Chemistry: Chemical cage captures a variety of compounds, regardless of charge.

A Personal Meter For Everything

Sensors: System allows glucose monitors to measure other analytes.

The (Synthetic) Nose Knows

Bioelectronics: Chemical sensor combines olfactory proteins and carbon nanotubes to mimic biology.

Text Size A A

Researchers have identified and tested a compound that reverses and prevents symptoms of neurodegenerative diseases like Alzheimer’s and Huntington’s in animal models (Cell, DOI: 10.1016/j.cell.2011.05.020; Curr. Biol., DOI: 10.1016/j.cub.2011.04.028). Neurodegeneration, the breakdown or death of neurons, causes losses in one’s ability to think, move, and communicate, often leading to death.

The compound, JM6, offers new hope for treating these diseases, for which new medications are urgently needed. Still, JM6’s safety and efficacy have yet to be confirmed in clinical trials.

The work was carried out by neuropharmacologist Robert Schwarcz of the University of Maryland School of Medicine; neurodegeneration specialist Paul J. Muchowski and his father, synthetic chemist Joseph M. Muchowski, both of Gladstone Institute of Neurological Disease; neurogeneticist Flaviano Giorgini of the University of Leicester, England; and coworkers. The research team hopes to have JM6 in human trials within two years, sponsored by a major drug firm or by a biotech company they are thinking about starting.

In animals, JM6 converts to an inhibitor of kynuren ine 3-monooxygenase, an enzyme that controls the kynurenine pathway, long believed to be implicated in neurodegeneration. This link was established to a large degree by Schwarcz’s group.

Levels of nerve-damaging kynurenine metabolites are elevated, and those of a neuroprotective one are lowered, in the blood of patients with neurodegenerative diseases. The researchers show that administering JM6 to animals with neurodegenerative diseases causes levels of the damaging and protective metabolites to normalize, leading to reversal and prevention of neuron damage.

JM6’s activity “seems like a fairy tale—almost too good to be true,” says Stephen Snyder, a deputy division director at the National Institute on Aging. “But intuitively you want JM6 to work out because it is simple and elegant, it’s good for the brain, and it appears to be nontoxic.”

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
<object width=“526″ height=“374″>
Advertisements

Über hinterauer

Pensionated Radiologist, interested in Green Chemistry, Technology, Environment and Share | var addthis_config = {"data_track_clickback":true}; nce.
Dieser Beitrag wurde unter English, Medizin, Medizin Allgemein, Wissenschaft, Zukunft abgelegt und mit , , , verschlagwortet. Setze ein Lesezeichen auf den Permalink.

2 Antworten zu Compound Prevents Neurodegeneration

  1. hinterauer schreibt:

    A new hope in Neurodegenerative Disease in an Aging Society of atmost Importance.

  2. hinterauer schreibt:

    Medicine is improving exponentially from now on.

Kommentar verfassen

Trage deine Daten unten ein oder klicke ein Icon um dich einzuloggen:

WordPress.com-Logo

Du kommentierst mit Deinem WordPress.com-Konto. Abmelden / Ändern )

Twitter-Bild

Du kommentierst mit Deinem Twitter-Konto. Abmelden / Ändern )

Facebook-Foto

Du kommentierst mit Deinem Facebook-Konto. Abmelden / Ändern )

Google+ Foto

Du kommentierst mit Deinem Google+-Konto. Abmelden / Ändern )

Verbinde mit %s